On Friday, Axonics Inc (AXNX) stock saw a decline, ending the day at $69.15 which represents a decrease of $-0.10 or -0.14% from the prior close of $69.25. The stock opened at $69.26 and touched a low ...

California-based medical device company Axonics has won a patent infringement trial against Medtronic, according to a Sept. 19 report from Global Data. Medtronic alleged that the company copied three ...

A federal jury in California has found that Axonics’ neurostimulators and electric leads for treating incontinence do not run ...

Abbott rolled out its first over-the-counter glucose sensor in the U.S. on Thursday, just over one week after Dexcom began selling its competing product. The device, called Lingo, is intended to be ...

Medical device maker Axonics has convinced a jury in California federal court that it did not violate rival Medtronic's ...

Meanwhile, Boston Scientific is still waiting for antitrust regulators to conclude their review of its proposal to buy ...

Axonics (Nasdaq:AXNX) announced today that a jury unanimously ruled in its favor in a patent spat with (NYSE: MDT).

The Court for the Central District of California has sided with Axonics finding the company did not breach Medtronic’s ...

Piper Sandler analyst Adam Maeder maintained a Hold rating on Axonics Modulation Technologies (AXNX – Research Report) today and set a ...

Axonics founder and CEO Raymond Cohen accepts a Business Journal Innovator of the Year award during a Sept. 12 ceremony.

Evecxia Therapeutics?the first company dedicated to realizing the therapeutic potential of Serotonin Synthesis Amplification to treat CNS disorders?today announced Dr. Jacob Pade Ramsøe Jacobsen, the ...

A jury unanimously found that Axonics did not infringe any of the three patents-in-suit brought against the company by Medtronic in a patent infringement lawsuit in the U.S. District Court for the ...